Heather M Moore

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 13

Top Topics

Positive Breast Cancer

Estrogen Receptor

Locally Advanced

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

NPJ breast cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Miguel Martin, Elgene Lim, Mariana Chavez Mac Gregor, Aditya Bardia, Jiong Wu, Qingyuan Zhang, Zbigniew Nowecki, Felipe José Silva Melo Cruz, Rustem Safin, Sung-Bae Kim, Christian Schem, Alberto J Montero, Sarah Khan, Reeti Bandyopadhyay, Heather M Moore, Mahesh Shivhare, Monika Patre, Jorge Martinalbo, Laura Roncoroni, Pablo Diego Pérez-Moreno, Joo Hyuk Sohn, null null
Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (18) (2024)
Miguel Martin, Elgene Lim, Mariana Chavez Mac Gregor, Aditya Bardia, Jiong Wu, Qingyuan Zhang, Zbigniew Nowecki, Felipe José Silva Melo Cruz, Rustem Safin, Sung-Bae Kim, Christian Schem, Alberto J Montero, Sarah Khan, Reeti Bandyopadhyay, Heather M Moore, Mahesh Shivhare, Monika Patre, Jorge Martinalbo, Laura Roncoroni, Pablo Diego Pérez-Moreno, Joo Hyuk Sohn, null null
Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Nayan Chaudhary, Alejandro M Chibly, Ann Collier, Jorge Martinalbo, Pablo Perez-Moreno, Heather M Moore, Patricia Luhn, Ciara Metcalfe, Marc Hafner
CDK4/6i-treated HR+/HER2- breast cancer tumors show higher ESR1 mutation prevalence and more altered genomic landscape. NPJ breast cancer 10 (1) (2024)
Miguel Martin, Elgene Lim, Mariana Chavez Mac Gregor, Aditya Bardia, Jiong Wu, Qingyuan Zhang, Zbigniew Nowecki, Felipe José Silva Melo Cruz, Rustem Safin, Sung-Bae Kim, Christian Schem, Alberto J Montero, Sarah Khan, Reeti Bandyopadhyay, Heather M Moore, Mahesh Shivhare, Monika Patre, Jorge Martinalbo, Laura Roncoroni, Pablo Diego Pérez-Moreno, Joo Hyuk Sohn, null null
Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (18) (2024)
Miguel Martin, Elgene Lim, Mariana Chavez Mac Gregor, Aditya Bardia, Jiong Wu, Qingyuan Zhang, Zbigniew Nowecki, Felipe José Silva Melo Cruz, Rustem Safin, Sung-Bae Kim, Christian Schem, Alberto J Montero, Sarah Khan, Reeti Bandyopadhyay, Heather M Moore, Mahesh Shivhare, Monika Patre, Jorge Martinalbo, Laura Roncoroni, Pablo Diego Pérez-Moreno, Joo Hyuk Sohn, null null
Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Nayan Chaudhary, Alejandro M Chibly, Ann Collier, Jorge Martinalbo, Pablo Perez-Moreno, Heather M Moore, Patricia Luhn, Ciara Metcalfe, Marc Hafner
CDK4/6i-treated HR+/HER2- breast cancer tumors show higher ESR1 mutation prevalence and more altered genomic landscape. NPJ breast cancer 10 (1) (2024)
Miguel Martin, Elgene Lim, Mariana Chavez Mac Gregor, Aditya Bardia, Jiong Wu, Qingyuan Zhang, Zbigniew Nowecki, Felipe José Silva Melo Cruz, Rustem Safin, Sung-Bae Kim, Christian Schem, Alberto J Montero, Sarah Khan, Reeti Bandyopadhyay, Heather M Moore, Mahesh Shivhare, Monika Patre, Jorge Martinalbo, Laura Roncoroni, Pablo Diego Pérez-Moreno, Joo Hyuk Sohn, null null
Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (18) (2024)
Nayan Chaudhary, Alejandro M Chibly, Ann Collier, Jorge Martinalbo, Pablo Perez-Moreno, Heather M Moore, Patricia Luhn, Ciara Metcalfe, Marc Hafner
CDK4/6i-treated HR+/HER2- breast cancer tumors show higher ESR1 mutation prevalence and more altered genomic landscape. NPJ breast cancer 10 (1) (2024)
Miguel Martin, Elgene Lim, Mariana Chavez Mac Gregor, Aditya Bardia, Jiong Wu, Qingyuan Zhang, Zbigniew Nowecki, Felipe José Silva Melo Cruz, Rustem Safin, Sung-Bae Kim, Christian Schem, Alberto J Montero, Sarah Khan, Reeti Bandyopadhyay, Heather M Moore, Mahesh Shivhare, Monika Patre, Jorge Martinalbo, Laura Roncoroni, Pablo Diego Pérez-Moreno, Joo Hyuk Sohn, null null
Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (18) (2024)
Nayan Chaudhary, Alejandro M Chibly, Ann Collier, Jorge Martinalbo, Pablo Perez-Moreno, Heather M Moore, Patricia Luhn, Ciara Metcalfe, Marc Hafner
CDK4/6i-treated HR+/HER2- breast cancer tumors show higher ESR1 mutation prevalence and more altered genomic landscape. NPJ breast cancer 10 (1) (2024)
Komal L Jhaveri, Meritxell Bellet-Ezquerra, Nicholas C Turner, Sherene Loi, Aditya Bardia, Valentina Boni, Joo Hyuk Sohn, Tomas G Neilan, Rafael Villanueva-Vázquez, Peter Kabos, Laura García Estévez, Elena Lopez-Miranda, José Alejandro Pérez-Fidalgo, Jose Manuel Perez-Garcia, Jiajie Yu, Jill Fredrickson, Heather M Moore, Ching-Wei Chang, John W Bond, Jennifer Eng-Wong, Mary R Gates, Elgene Lim
Phase Ia/b Study of Giredestrant ±Palbociclib and ±Luteinizing Hormone-releasing Hormone Agonists in Estrogen Receptor-positive, HER2-negative, Locally Advanced/Metastatic Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Sarat Chandarlapaty, Maura N Dickler, José Alejandro Pérez-Fidalgo, Rafael Villanueva-Vázquez, Jennifer M Giltnane, Mary R Gates, Ching-Wei Chang, Sravanthi Cheeti, Jill Fredrickson, Xiaojing Wang, Ann Collier, Heather M Moore, Ciara Metcalfe, Jennifer Lauchle, Eric W Humke, Aditya Bardia
An open-label phase I study of GDC-0927 in postmenopausal women with locally advanced or metastatic estrogen receptor positive breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jackson Liang, Ellen Rei Ingalla, Xiaosai Yao, Bu-Er Wang, Lisa Tai, Jennifer M Giltnane, Yuxin Liang, Anneleen Daemen, Heather M Moore, Junko Aimi, Ching-Wei Chang, Mary R Gates, Jennifer Eng-Wong, Lucinda Tam, Natasha Bacarro, Merone Roose-Girma, Meritxell Bellet-Ezquerra, Marc Hafner, Ciara Metcalfe
Giredestrant reverses progesterone hypersensitivity driven by estrogen receptor mutations in breast cancer. Science translational medicine 14 (663) (2022)